Consider Recommending a Beta-Blocker for Surgery in High-Risk Patients
New guidelines will clarify when to use beta-blockers for noncardiac surgery.
Beta-blockers reduce nonfatal MI risk in high-risk patients undergoing noncardiac surgery...probably by decreasing cardiac workload.
But this benefit can come at a cost...bradycardia, hypotension, and possibly a higher risk of stroke and death.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote